Xylem (NYSE:XYL) Director D Christian Koch Acquires 11,000 Shares of Company Stock

Key Points

• Director D. Christian Koch purchased 11,000 Xylem shares at an average of $89.60 each, investing approximately $985,600 and increasing his direct ownership by 882% to 12,247 shares.
• Xylem’s latest quarter fell slightly short of expectations, with EPS of $1.44 versus $1.45 expected and revenue of $2.20 billion versus $2.28 billion; revenue declined 3% year over year.
• Analyst sentiment remains mixed: Xylem has an overall “Hold” rating and an average price target of $121.31, while several firms recently cut targets despite maintaining positive ratings.

Xylem Inc. (NYSE:XYL - Get Free Report) Director D Christian Koch bought 11,000 shares of the company's stock in a transaction that occurred on Thursday, October 29th. The shares were purchased at an average price of $89.60 per share, with a total value of $985,600.00. Following the transaction, the director directly owned 12,247 shares in the company, valued at $1,097,331.20. This represents a 882.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Xylem Price Performance

Xylem stock traded up $2.51 on Thursday, reaching $90.74. The company's stock had a trading volume of 4,918,256 shares, compared to its average volume of 2,172,384. Xylem Inc. has a twelve month low of $87.40 and a twelve month high of $154.27. The business's fifty day moving average price is $105.98 and its 200 day moving average price is $118.05. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61. The company has a market cap of $21.19 billion, a price-to-earnings ratio of 21.61, a PEG ratio of 1.75 and a beta of 1.00.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing the consensus estimate of $1.45 by ($0.01). The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.28 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%. The business's revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.37 EPS. Equities analysts expect that Xylem Inc. will post 5.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were given a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, August 27th. This represents a $1.72 annualized dividend and a dividend yield of 1.9%. Xylem's payout ratio is 40.95%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Jefferies Financial Group boosted their target price on Xylem from $145.00 to $150.00 and gave the stock a "buy" rating in a report on Monday, August 24th. Robert W. Baird set a $123.00 price target on Xylem in a research report on Wednesday. BNP Paribas Exane decreased their target price on Xylem from $145.00 to $135.00 and set an "outperform" rating on the stock in a research report on Wednesday. Oppenheimer cut their price target on shares of Xylem from $150.00 to $135.00 and set an "outperform" rating on the stock in a report on Wednesday. Finally, The Goldman Sachs Group decreased their target price on Xylem from $160.00 to $138.00 and set a "buy" rating for the company in a research note on Wednesday. Nine equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Xylem presently has an average rating of "Hold" and an average price target of $121.31.

Institutional Investors Weigh In On Xylem

Several hedge funds have recently added to or reduced their stakes in XYL. Woodmont Investment Counsel LLC increased its position in shares of Xylem by 5.7% in the third quarter. Woodmont Investment Counsel LLC now owns 49,043 shares of the industrial products company's stock valued at $4,967,000 after buying an additional 2,655 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich lifted its holdings in Xylem by 9.5% in the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 116,885 shares of the industrial products company's stock valued at $11,834,000 after purchasing an additional 10,149 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Xylem by 0.6% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 538,198 shares of the industrial products company's stock worth $54,503,000 after buying an additional 3,000 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Xylem in the third quarter worth about $6,299,000. Finally, SFE Investment Counsel lifted its stake in Xylem by 9.7% in the 3rd quarter. SFE Investment Counsel now owns 53,592 shares of the industrial products company's stock worth $5,427,000 after purchasing an additional 4,755 shares in the last quarter. Institutional investors own 87.96% of the company's stock.

Trending Headlines about Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: RBC initiated coverage with a moderate buy rating and a $125 price target, implying substantial upside from recent levels. RBC also reaffirmed its buy rating, while Citigroup, BNP Paribas Exane, Stifel, and Oppenheimer maintained positive ratings despite lowering their targets. RBC Capital Reaffirms Buy Rating
• Positive Sentiment: Unusually heavy call-option activity suggests some traders are positioning for a rebound: 20,508 calls changed hands, about 771% above average volume.
• Positive Sentiment: Some analysts view the selloff as excessive relative to Xylem’s longer-term growth potential. The company’s planned divestitures and new three-segment structure could streamline operations and sharpen its strategic focus.
• Neutral Sentiment: Analyst opinion is mixed. UBS lowered its price target to $99 and assigned a neutral rating, while Stifel reduced its target to $114 but retained a buy rating. The target reductions indicate more cautious near-term expectations even though most targets remain above the current share price.
• Negative Sentiment: Xylem’s third-quarter revenue of $2.20 billion missed the $2.28 billion consensus estimate, while adjusted EPS of $1.44 was slightly below expectations. Revenue declined 3% year over year, reinforcing concerns about slowing demand. Xylem Stock Price Sinks After Q3 Results
• Negative Sentiment: Management cut its 2026 outlook, a key reason for the post-earnings decline. JPMorgan downgraded the stock to underweight and lowered its target to $90, while elevated put-option activity points to continued downside hedging. Xylem Cuts 2026 Outlook
• Negative Sentiment: A law firm announced an investigation into potential securities-law violations related to the earnings shortfall, adding a further reputational and legal risk for shareholders. Xylem Investigation Notice

Xylem Company Profile

Xylem Inc NYSE: XYL is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company's products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.